论文部分内容阅读
AIM To investigate the safety and efficacy of addingbevacizumab to first-line chemotherapy in metastaticcolorectal cancer patients with peritoneal disease.METHODS: We compared rates of gastrointestinalperforation in patients with metastatic colorectal can